A strong infectious diseases workforce is essential to protecting patients, stresses IDSA member Vera Luther, MD, FIDSA. #ValueofID
Thank you, Sen. @CortezMasto, for raising this critical issue during yesterday's @SenFinance hearing.
La #TUBERCULOSIS en una gran #imitadora y a veces se “hace pasar” por neoplasias,sospéchala!!!📸👇🏻😜
Ejplos:
🦀Ca pulmón➕metast. vertebrales🔗 https://t.co/jA2pOFfuZ1
🦀Ca ovario🔗https://t.co/GhZNstebSL
🦀Ca pancreas🔗 https://t.co/RbuQQiJQ7X
Y muchos más!Cerebral,Testicular…
Increasingly, public health experts have recognized that testing and treatment alone won’t curb the more-than-decade-long rise of US syphilis cases, which in 2022 reached the highest number since 1950, according to the CDC. https://t.co/cz4T52NWlE
We're excited to announce our brand new State-of-the-Art Reviews collection page!
These articles address nuances in clinical decision-making, including clinical presentations, diagnostic approaches, and management.
See the full collection here ➡️ https://t.co/FDJaypCEm7
The BLING III trialists summarise their presentation from CCR24 this morning
Simultaneously published in @JAMA_current
Trial: https://t.co/RW9h28iaZR
SRMA: https://t.co/JyGkEgC0P2
Editorial: https://t.co/7Kgboa9kAs
Interview: https://t.co/SZGolhnYTZ
Infectious diseases is one of the least evidence-based specialities in medicine (see below)
It has "an unusual amount of dogma based on myth and lore that people believe with near religious fervor"
Not great for an evidence-based pandemic response?
https://t.co/msMDOv8AGd
SCOOP: The U.S. is preparing to send Mexico the Moderna vaccine for the first time -- despite the fact that it still needs regulatory approval in 🇲🇽 -- as well as AstraZeneca.
AMLO and VP Harris will talk vaccines today.
My story with @JenniferJJacobs
https://t.co/aF3OnEWKhc
The irony of giving tocilizumab to unvaccinated patients who wouldn’t get vaccinated because it hasn’t been studied long enough is something I can’t get over
In autologous stem cell transplant recipients, initiation of antimicrobial prophylaxis upon neutropenia appears to be safe and results in nearly a 50% reduction in prophylactic antimicrobial use https://t.co/ePZyh1So4x
SARS-CoV-2 Delta variant in an infected cell. Another masterpiece from Dr Jason Roberts - Electron Microscopy and Structural Virology Head at the #DohertyInstitute@pteropid@TheRMH @UniMelbMDHS @UniMelbMDHS
New CDC MMWR finds people with severe HIV in sub-Saharan Africa were more likely to have severe illness or die from COVID-19. Ensuring treatment for people living w/ HIV can help limit COVID-19-related illness & death. More: https://t.co/LfCxdgw66i
💥Breaking news💥
Finally
WHO has announced a new naming system for key #COVID19 variants. The labels are based on the Greek alphabet (i.e. Alpha, Beta, Gamma, etc), making them simple, easy to say and remember. https://t.co/fiDoBSXA5B
Fungus balls of 𝘈𝘴𝘱𝘦𝘳𝘨𝘪𝘭𝘭𝘶𝘴 𝘯𝘪𝘨𝘦𝘳 hyaline hyphae growing in broth culture. 𝘈. 𝘯𝘪𝘨𝘦𝘳’s dark conidia have not formed because the fungus is not in contact with air.
Study of a nursing home outbreak. A person sent to vaccinate residents was likely infected. 73 of 76 residents received at least one dose of the Pfizer-BNT vaccine, but this wasn’t enough to prevent deaths in 5 people who tested positive on day 20.
https://t.co/3voN7Hpidh
Pfizer says new clinical trials showed its COVID-19 vaccine shows "100% efficacy" in young people ages 12-15.
The company says it'll submit the results to the FDA "as soon as possible."
https://t.co/eBLqQlK05S